The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation

References

• LammersTKiesslingFHenninkWEStormGDrug targeting to tumors: principles, pitfalls and (pre-) clinical progressJ Control Release2012161217518721945285
   PubMed Web of Science ®Google Scholar
• ValenciaPMHanewich-HollatzMHGaoWEffects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticlesBiomaterials201132266226623321658757
   PubMed Web of Science ®Google Scholar
• XiaoZLevy-NissenbaumEAlexisFEngineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selectionACS Nano20126169670422214176
   PubMed Web of Science ®Google Scholar
• WangWChengDGongFMiaoXShuaiXDesign of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imagingAdv Mater201224111512022143956
   PubMed Web of Science ®Google Scholar
• Eldar-BoockAMillerKSanchisJLupuRVicentMJSatchi-FainaroRIntegrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxelBiomaterials201132153862387421376390
   PubMed Web of Science ®Google Scholar
• YangZLuoXZhangXLiuJJiangQTargeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticlesBiomed Mater20138202501223507576
   PubMed Web of Science ®Google Scholar
• ChenZDengJZhaoYTaoTCyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in ratsInt J Nanomedicine201273803381122888235
   PubMed Web of Science ®Google Scholar
• CaiLLLiuPLiXRGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cellsInt J Nanomedicine201163499350822282676
   PubMed Web of Science ®Google Scholar
• ZhaoBJKeXYHuangYThe antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in ratsJ Drug Target201119538239020677914
   PubMed Web of Science ®Google Scholar
• LuoLMHuangYZhaoBXAnti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelBiomaterials20133441102111423127332
   PubMed Web of Science ®Google Scholar
• SugaharaKNTeesaluTKarmaliPPTissue-penetrating delivery of compounds and nanoparticles into tumorsCancer Cell200916651052019962669
   PubMed Web of Science ®Google Scholar
• SugaharaKNTeesaluTKarmaliPPCoadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsScience201032859811031103520378772
   PubMed Web of Science ®Google Scholar
• ZhuZXieCLiuQThe effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticlesBiomaterials201132359525953521903260
   PubMed Web of Science ®Google Scholar
• SongWLiMTangZMethoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancersMacromol Biosci201212111514152323070837
   PubMed Web of Science ®Google Scholar
• WangXZhenXWangJZhangJWuWJiangXDoxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticlesBiomaterials201334194667467923537667
   PubMed Web of Science ®Google Scholar
• SuSWangHLiuXWuYNieGiRGD-coupled responsive fluorescent nanogel for targeted drug deliveryBiomaterials201334133523353323410678
   PubMed Web of Science ®Google Scholar
• Hai-TaoZHui-ChengLZheng-WuLChang-HongGA tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivoAnticancer Drugs201122540941521427563
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
   PubMed Web of Science ®Google Scholar
• HuwylerJDreweJKrähenbuhlSTumor targeting using liposomal antineoplastic drugsInt J Nanomedicine200831212918488413
   PubMed Web of Science ®Google Scholar
• MoghimiSMPatelHMOpsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cellsBiochim Biophys Acta1992113532692741623013
   PubMed Web of Science ®Google Scholar
• LasicDDDoxorubicin in sterically stabilized liposomesNature199638065745615628606781
   PubMed Web of Science ®Google Scholar
• YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res19955517375237567641188
   PubMed Web of Science ®Google Scholar
• MaruyamaKIntracellular targeting delivery of liposomal drugs to solid tumors based on EPR effectsAdv Drug Deliv Rev201163316116920869415
   PubMed Web of Science ®Google Scholar
• RatheeshAIngleAGudeRPPentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix componentsCancer Biol Ther20076111743175217986856
   PubMed Web of Science ®Google Scholar
• MazurekAMOlbrytMThe influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cellsNeoplasma2012591435122082309
   PubMed Web of Science ®Google Scholar
• ZhaoBXZhaoYHuangYThe efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxelBiomaterials20123382508252022197569
   PubMed Web of Science ®Google Scholar
• YangTWangYLiZTargeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculatureNanomedicine201281819221664295
   PubMed Web of Science ®Google Scholar
• WangYYangTWangXMaterializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle systemJ Control Release2011149329930621044651
   PubMed Web of Science ®Google Scholar
• MarcucciFCortiAHow to improve exposure of tumor cells to drugs: promoter drugs increase tumor uptake and penetration of effector drugsAdv Drug Deliv Rev2012641536821983328
   PubMed Web of Science ®Google Scholar
• GoodmanSLPicardMIntegrins as therapeutic targetsTrends Pharmacol Sci201233740541222633092
   PubMed Web of Science ®Google Scholar
• NemethJANakadaMTTrikhaMAlpha-v integrins as therapeutic targets in oncologyCancer Invest200725763264618027153
   PubMed Web of Science ®Google Scholar
• TuckerGCAlpha v integrin inhibitors and cancer therapyCurr Opin Investig Drugs200346722731
   PubMedGoogle Scholar
• BagriATessier-LavigneMWattsRJNeuropilins in tumor biologyClin Cancer Res20091561860186419240167
   PubMed Web of Science ®Google Scholar
• EllisLMThe role of neuropilins in cancerMol Cancer Ther2006551099110716731741
   PubMed Web of Science ®Google Scholar
• CaoJWanSTianJFast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosisContrast Media Mol Imaging20127439040222649045
   PubMed Web of Science ®Google Scholar
• BiswasSWangXMoralesARAhnHYBelfieldKDIntegrin-targeting block copolymer probes for two-photon fluorescence bioimagingBiomacromolecules201112244144921190348
   PubMed Web of Science ®Google Scholar
• NasarrePConstantinBRouhaudLSemaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreadingNeoplasia200351839212659673
   PubMed Web of Science ®Google Scholar
• VailDMAmanteaMAColbernGTMartinFJHilgerRAWorkingPKPegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studiesSemin Oncol2004316 Suppl 13163515717736
   PubMed Web of Science ®Google Scholar
• AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
   PubMed Web of Science ®Google Scholar
• PastorinoFBrignoleCMarimpietriDVascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapyCancer Res200363217400740914612539
   PubMed Web of Science ®Google Scholar
• Al-JamalWTAl-AhmadyZSKostarelosKPharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermiaBiomaterials201233184608461722459195
   PubMed Web of Science ®Google Scholar
• DaiWYangTWangYPeptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanomaNanomedicine2012871152116122306158
   PubMed Web of Science ®Google Scholar
• FanYDuWHeBThe reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicinBiomaterials20133492277228823290525
   PubMed Web of Science ®Google Scholar